acrolein has been researched along with clindamycin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Mirjani, R; Monsef-Esfahani, HR; Shahverdi, AR; Tavasoli, F; Zaheri, A | 1 |
2 other study(ies) available for acrolein and clindamycin
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Trans-cinnamaldehyde from Cinnamomum zeylanicum bark essential oil reduces the clindamycin resistance of Clostridium difficile in vitro.
Topics: Acrolein; Anti-Bacterial Agents; Chromatography, Thin Layer; Cinnamomum zeylanicum; Clindamycin; Clostridioides difficile; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Synergism; Microbial Sensitivity Tests; Oils, Volatile | 2007 |